Analysed KALA BIO INC (KALA:NASDAQ) News Sources
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
21-04-2026
yahoo.com
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
01-04-2026
yahoo.com
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
30-03-2026
yahoo.com
Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate
18-03-2026
yahoo.com
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
18-03-2026
yahoo.com
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents
11-03-2026
yahoo.com
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
11-03-2026
yahoo.com
What is the current price of KALA BIO INC (KALA:NASDAQ)?
The current price of KALA BIO INC (KALA:NASDAQ) is $0.1772.
KALA BIO INC (KALA:NASDAQ) absolute price change since previous trading day?
The absolute price change of KALA BIO INC (KALA:NASDAQ) since the previous trading day is $-0.0079.
KALA BIO INC (KALA:NASDAQ) percentage price change since previous trading day?
The percentage price change of KALA BIO INC (KALA:NASDAQ) since the previous trading day is -4.268%.
What is the most recent average sentiment score for KALA BIO INC (KALA:NASDAQ)?
The most recent average sentiment score for KALA BIO INC (KALA:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for KALA BIO INC (KALA:NASDAQ)?
The most recent sentiment for KALA BIO INC (KALA:NASDAQ) is .
SEC-8K** Filing Available For KALA BIO INC (KALA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.